Vsee Health, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
VSee Health reports a net loss of $2.6 million for Q1 2026 amid ongoing liquidity challenges and material weaknesses in internal controls.
NASDAQ
VSee Health reported a 1050% increase in net loss to $6.57 million for the first half of 2025 despite a 101% revenue surge, driven by higher operating expenses and fair value losses on financial instruments.
NASDAQ
VSee Health, Inc. reported a 60% revenue increase for the nine months ended September 30, 2025, driven by its iDoc acquisition, but faces substantial doubt about its ability to continue as a going concern due to persistent operating losses and liquidity challenges.
NASDAQ
VSee Health, Inc. reported a significant 1050% increase in net loss for Q2 2025, raising substantial doubt about its ability to continue as a going concern amidst internal control weaknesses and ongoing financing needs.
NASDAQ
VSee Health, Inc. reported a significant net loss of $3.96 million in Q1 2025, despite a 105% revenue increase, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
VSee Health's Q3 2024 results show a significant net loss due to a large goodwill impairment charge, despite revenue growth driven by recent acquisitions.
NASDAQ
VSee Health, Inc. reports its second quarter 2024 financial results, which include the impact of a recent business combination and a reverse recapitalization.
NASDAQ
Digital Health Acquisition Corp. reports a net loss of $967,817 for the first quarter of 2024, while continuing efforts to finalize its business combination.